The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index, and 1 are not checked yet.
Subclinical hyperthyroidism: clinical features and treatment options
Abstract
Subclinical hyperthyroidism appears to be a common disorder. It may be caused by exogenous or endogenous factors: excessive TSH suppressive therapy with l -thyroxine ( l -T4) for benign thyroid nodular disease, differentiated thyroid cancer, or hormone over-replacement in patients with hypothyroidism are the most frequent causes. Consistent evidence indicates that ‘subclinical’ hyperthyroidism reduces the quality of life, affecting both the psycho and somatic components of well-being, and produces relevant signs and symptoms of excessive thyroid hormone action, often mimicking adrenergic overactivity. Subclinical hyperthyroidism exerts many significant effects on the cardiovascular system; it is usually associated with a higher heart rate and a higher risk of supra-ventricular arrhythmias, and with an increased left ventricular mass, often accompanied by an impaired diastolic function and sometimes by a reduced systolic performance on effort and decreased exercise tolerance. It is well known that these abnormalities usually precede the onset of a more severe cardiovascular disease, thus potentially contributing to the increased cardiovascular morbidity and mortality observed in these patients. In addition, it is becoming increasingly apparent that subclinical hyperthyroidism may accelerate the development of osteoporosis and hence increased bone vulnerability to trauma, particularly in postmenopausal women with a pre-existing predisposition. Subclinical hyperthyroidism and its related clinical manifestations are reversible and may be prevented by timely treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Suppression of TSH may also be iatrogenic (exogenous) due to thyroid hormone overtreatment, either intentionally (in patients with thyroid cancer), unintentionally (in patients with hypothyroidism) or surreptitiously [2,3] ( table 1 ).”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [2]
Citations
Cites
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
THE EPIDEMIOLOGY OF THYROID DISEASE AND IMPLICATIONS FOR SCREENING
Wang, C., & Crapo, L. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70240-1 · Cited by 520
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Research works printed but not linked: 20
- 1996, Journal of Clinical Endocrinology & Metabolism, 56, 283
- STOTT, 1991, QJM, 78, 77
- Drinka, 1999, Geriatrics, 54, 58
- 1977, Endocrinology and metabolism clinics of North America, 26, 189
- Dunn, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 486, 10.1210/jc.87.2.486 · DOI
- Mercuro, 2000, Journal of Clinical Endocrinology & Metabolism, 85, 159, 10.1210/jc.85.1.159 · DOI
- Biondi, 1999, Cardiologia (Rome, Italy), 44, 443
- Biondi, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 2643, 10.1210/jc.83.8.2643 · DOI
- 1999, Journal of internal medicine, 228, 229
- 2001, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES, 109, S37
- 1988, Circulation, 98, 946
- Fazio, 1995, Journal of Clinical Endocrinology & Metabolism, 80, 2222, 10.1210/jc.80.7.2222 · DOI
- Biondi, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 4224, 10.1210/jc.81.12.4224 · DOI
- Rosen, 1992, Journal of Clinical Endocrinology & Metabolism, 75, 1531, 10.1210/jc.75.6.1531 · DOI
- 1990, Journal of Clinical Endocrinology & Metabolism, 72, 1184
- Marcocci, 1994, Journal of Clinical Endocrinology & Metabolism, 78, 818, 10.1210/jc.78.4.818 · DOI
- Adlin, 1991, The American journal of medicine, 90, 360, 10.1016/0002-9343(91)80017-g · DOI
- 1977, Journal of Clinical Endocrinology & Metabolism, 82, 2931
- Rosen, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 2324, 10.1210/jc.83.7.2324 · DOI
- Rosen, 1993, Journal of Clinical Endocrinology & Metabolism, 77, 664, 10.1210/jc.77.3.664 · DOI
Cited by
Sorted by citations
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Self-citationState-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
Maratou, E., Hadjidakis, D., Κόλλιας, Α., TSEGKA, K. G., Peppa, Μ., Alevizaki, M., Mitrou, P., Lambadiari, V., Boutati, E. I., Nikzas, D., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0797 · Cited by 467
Subclinical Hyperthyroidism and Pregnancy Outcomes
Casey, B. M., Dashe, J. S., Wells, C. E., McIntire, D. D., Leveno, K. J., & Cunningham, F. G. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000197991.64246.9a · Cited by 358
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationMECHANISMS IN ENDOCRINOLOGY: Heart failure and thyroid dysfunction
Biondi, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0627 · Cited by 291
Self-citationSmoking and hormones in health and endocrine disorders
Kapoor, D., & Jones, T. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01867 · Cited by 291
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
Self-citationDiagnostic Criteria for Moyamoya Disease - 2021 Revised Version
Kuroda, S., Fujimura, M., TAKAHASHI, J. C., Kataoka, H., Ogasawara, K., Iwama, T., Tominaga, T., & Miyamoto, S. (2022) · Neurologia medico-chirurgica · doi:10.2176/jns-nmc.2022-0072 · Cited by 285
Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
Miller, M. D., Crofton, K. M., Rice, D. C., & Zoeller, R. T. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800247 · Cited by 289
Ballesteros, V., Costa, O., Iñiguez, C., Fletcher, T., Ballester, F., & Lopez-Espinosa, M.-J. (2017) · Environment International · doi:10.1016/j.envint.2016.10.015 · Cited by 242
Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules
Baek, J. H., Moon, W., Kim, Y. S., Lee, J. H., & Lee, D. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0130-3 · Cited by 234
Cardiovascular involvement in patients with different causes of hyperthyroidism
Biondi, B., & Kahaly, G. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.105 · Cited by 230
Self-citationCozzi, R. C., Montini, M., Attanasio, R., Albizzi, M., Lasio, G. B., Lodrini, S., Doneda, P., Cortesi, L., & Pagani, G. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2347 · Cited by 224
Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies
Kadiyala, R. U., Peter, R., & Okosieme, O. E. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02376.x · Cited by 231
Thyroid-hormone therapy and thyroid cancer: a reassessment
Biondi, B., Filetti, S., & Schlumberger, M. J. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0020 · Cited by 222
Self-citationIs there a need to redefine the upper normal limit of TSH?
Brabant, G., Beck-Peccoz, P., Jarzab, B., Laurberg, P., Orgiazzi, J., Szabolcs, I., Weetman, A. P., & Wiersinga, W. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02136 · Cited by 211
Colao, A. A. L., Attanasio, R., Pivonello, R., Cappabianca, P., Cavallo, L. M., Lasio, G. B., Lodrini, A., Lombardi, G., & Cozzi, R. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1208 · Cited by 191
Self-citationHaentjens, P., Van Meerhaeghe, A., Poppe, K., & Velkeniers, B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0110 · Cited by 174
Primary hyperparathyroidism and the skeleton
Mosekilde, L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03162.x · Cited by 168
Hovens, G. C., Stokkel, M. P. M., Kievit, J., Corssmit, E. P. M., Pereira, A. M., Romijn, J. A., & Smit, J. W. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2566 · Cited by 163
Morris, M. S. (2007) · Bone · doi:10.1016/j.bone.2006.12.001 · Cited by 129
Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss
Sun, L., Vukičević, S., Baliram, R., Yang, G., Sendak, R. A., McPherson, J. M., Zhu, L.-L., Iqbal, J. Z., Latif, R., Natrajan, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712395105 · Cited by 126
β2‐adrenoceptors are critical for antidepressant treatment of neuropathic pain
Yalçın, İ., Choucair‐Jaafar, N., Benbouzid, M., Tessier, L., Muller, A., Hein, L., Freund‐Mercier, M. J., & Barrot, M. (2009) · Annals of Neurology · doi:10.1002/ana.21542 · Cited by 131
Psychiatric Manifestations of Graves??? Hyperthyroidism
Bunevičius, R., & Prange, A. J. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00003 · Cited by 120
Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism
Maratou, E., Hadjidakis, D., Peppa, Μ., Alevizaki, M., TSEGKA, K. G., Lambadiari, V., Mitrou, P., Boutati, E. I., Κόλλιας, Α., Economopoulos, T., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0246 · Cited by 114
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
Self-citationVillagelin, D., Romaldini, J. H., dos Santos, R. B., Milkos, A. B. B. P., & Ward, L. S. (2015) · Thyroid · doi:10.1089/thy.2015.0195 · Cited by 100
Duntas, L. H., & Biondi, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02310 · Cited by 98
Self-citationNonsurgical approaches to the management of thyroid nodules
Filetti, S., Durante, C., & Torlontano, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0215 · Cited by 93
Self-citationDøssing, H., Bennedbæk, F. N., Bonnema, S. J., Grupe, P., & Hegedűs, L. D. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0094 · Cited by 93
Thyroid disruption: mechanism and clinical implications in human health.
Patrick, L. (2009) · PubMed · Cited by 92
Subclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis
Wirth, C. D., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0125 · Cited by 85
Approach to the Patient with Subclinical Hyperthyroidism
Cooper, D. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2472 · Cited by 83
Fracture Risk in Patients Treated for Hyperthyroidism
Vestergaard, P., Rejnmark, L., Weeke, J., & Mosekilde, L. (2000) · Thyroid · doi:10.1089/thy.2000.10.341 · Cited by 80
Metabolic and Clinical Consequences of Hyperthyroidism on Bone Density
Gorka, J., Taylor‐Gjevre, R. M., & Arnason, T. (2013) · International Journal of Endocrinology · doi:10.1155/2013/638727 · Cited by 83
Medical Treatment of Acromegaly: Comorbidities and Their Reversibility by Somatostatin Analogs
Tolis, G., Angelopoulos, N., Katounda, E., Rombopoulos, G., Kaltzidou, V., Kaltsas, D., Protonotariou, A., & Lytras, A. (2006) · Neuroendocrinology · doi:10.1159/000095535 · Cited by 68
Cianfarani, S., Liguori, A., Boemi, S., Maghnie, M., Iughetti, L., Wasniewska, M. G., Street, M. E., Zucchini, S., Aimaretti, G., & Germani, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0721 · Cited by 65
Thyroid Disrupting Chemicals in Plastic Additives and Thyroid Health
Andra, S. S., & Makris, K. C. (2012) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2012.681487 · Cited by 61
Possible Limited Bone Loss with Suppressive Thyroxine Therapy Is Unlikely to Have Clinical Relevance
Müller, C., BAYLEY, T. A., Harrison, J. E., & TSANG, R. (1995) · Thyroid · doi:10.1089/thy.1995.5.81 · Cited by 59
Byrne, S. C., Miller, P. K., Seguinot-Medina, S., Waghiyi, V., Buck, C. L., von Hippel, F. A., & Carpenter, D. O. (2018) · Environmental Research · doi:10.1016/j.envres.2018.06.014 · Cited by 59
Nontoxic Diffuse and Nodular Goiter and Thyroid Neoplasia
Schlumberger, M.-J., Filetti, S., & HAY, I. D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00014-6 · Cited by 57
Self-citationYue, W., Chong, B.-H., Zhang, X.-H., Liao, S.-Y., Jim, M., Kung, A. W. C., Tse, H., & Siu, C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03981.x · Cited by 54
Metabolic Effects of ??-Adrenoceptor Antagonists with Special Emphasis on Carvedilol
Kveiborg, B., Christiansen, B., Major‐Pedersen, A., & Torp-Pedersen, C. T. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00001 · Cited by 52
TSH receptor activation and body composition
Lloyd, A. D., Bursell, J., Gregory, J. W., Rees, A., & Ludgate, M. E. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0262 · Cited by 51
Arrhythmia and thyroid dysfunction
Marrakchi, S., Kanoun, F., Idriss, S., Kammoun, I., & Kachboura, S. (2014) · Herz · doi:10.1007/s00059-014-4123-0 · Cited by 49
Barrio, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0644 · Cited by 52
Mazziotti, G., Mormando, M., Cristiano, A., Bianchi, A., Porcelli, T., Giampietro, A., Maffezzoni, F., Serra, V, De Marinis, L., & Giustina, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0097 · Cited by 48
Byrne, S. C., Miller, P. K., Seguinot-Medina, S., Waghiyi, V., Buck, C. L., von Hippel, F. A., & Carpenter, D. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-20443-9 · Cited by 47
Kaminski, G., Michalkiewicz, D., Makowski, K., Podgajny, Z., Szalus, N., Ruchala, M., Szczepanek, E., & Gielerak, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03957.x · Cited by 45
An Analysis of the Natural Course of Subclinical Hyperthyroidism
Díez, J. J., & Iglesias, P. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318187e16d · Cited by 45
The Management of Subclinical Hyperthyroidism by Thyroid Specialists
McDermott, M. T., Woodmansee, W. W., Haugen, B. R., Smart, A., & Ridgway, E. C. (2003) · Thyroid · doi:10.1089/10507250360731532 · Cited by 45
Minimally Invasive Ablation of a Toxic Thyroid Nodule by High-Intensity Focused Ultrasound
Esnault, O., Rouxel, A., Nestour, E. L., Gheron, G., & Leenhardt, L. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1979 · Cited by 44
Management of Subclinical Hyperthyroidism
Palacios, S. S., Corrales, E. P., & Galofré, J. C. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.3447 · Cited by 44
Evaluation of thyroid function status among postmenopausal women with and without osteoporosis
Acar, B., Özay, A. C., Özay, Ö. E., Okyay, R. E., Şişman, A. R., & Özaksoy, D. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.11.025 · Cited by 41
Health Status, Mood, and Cognition in Experimentally Induced Subclinical Thyrotoxicosis
Samuels, M. H., Schuff, K. G., Carlson, N. E., Carello, P., & Janowsky, J. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1957 · Cited by 39
(2007) · PubMed · Cited by 39
Abraham‐Nordling, M., Wallin, G., Lundell, G. E. F., & Törring, O. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02336 · Cited by 39
Endothelial dysfunction in subjects with subclinical hyperthyroidism
Çoban, E., Aydemir, M., Yazicioglu, G., & Özdoğan, M. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345539 · Cited by 36
Yang, R., Yao, L., Fang, Y., Sun, J., Guo, T., Yang, K., & Tian, L. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0828-5 · Cited by 35
RetractedScott‐Moncrieff, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00004-3 · Cited by 35
Boeloni, J. N., Ocarino, N. M., de Melo, A. B. S., Silva, J. F., Castanheira, P., Goes, A. M., & Serákides, R. (2009) · Hormone Research in Paediatrics · doi:10.1159/000232161 · Cited by 35
Thyroid functional and molecular imaging
Giovanella, L., Avram, A. M., Ovčariček, P. P., & Clerc, J. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104116 · Cited by 32
Management of thyroid disorders
Premawardhana, L. D. K. E., & Lazarus, J. H. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.047290 · Cited by 34
Altered expression of progesterone receptors in testis of infertile men
Abid, S., Gokral, J., Maitra, A., Meherji, P. K., Kadam, S. S., Pires, E. S., & Modi, D. N. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60192-7 · Cited by 32
Abdulrahman, R. M., Delgado, V., Ng, A. C. T., Ewe, S. H., Bertini, M., Holman, E. R., Hovens, G. C., Pereira, A. M., Romijn, J. A., Bax, J. J., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0328 · Cited by 31
Patanè, S., Marte, F., & Sturiale, M. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.10.001 · Cited by 31
Mandel, S. J., Larsen, P. R., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00012-2 · Cited by 31
Depressive Symptoms and Hypomagnesemia in Older Diabetic Subjects
Barragan-Rodríguez, L., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.03.008 · Cited by 29
Patanè, S., & Marte, F. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.023 · Cited by 29
Zhu, H., Zhang, J., Wang, J., Zhao, X., & Gu, M. (2020) · Endocrine · doi:10.1007/s12020-019-02110-9 · Cited by 28
Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
Giovanella, L., Avram, A. M., & Clerc, J. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246017 · Cited by 28
Cardiovascular Complications Secondary to Graves’ Disease: A Prospective Study from Ukraine
Tsymbalyuk, I., Unukovych, D., Швец, Н. И., & Dinets, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122388 · Cited by 28
Radicioni, A. F., Lenzi, A., Spaziani, M., Anzuini, A., Ruga, G., Papi, G., Raimondo, M., & Foresta, C. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03347112 · Cited by 27
Should we treat mild subclinical/mild hyperthyroidism? Yes
Wiersinga, W. M. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.03.008 · Cited by 27
Diagnosing and Managing Thyroid Disease in the Nursing Home
Dominguez, L. J., Bevilacqua, M. T., Bella, G. D., & Barbagallo, M. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.07.011 · Cited by 26
Should we treat all subjects with subclinical thyroid disease the same way?
Biondi, B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0527 · Cited by 25
Self-citationThyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management
Triggiani, V., & Iacoviello, M. (2013) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530311313010005 · Cited by 25
Jorde, R., Joakimsen, O., Stensland, E., & Mathiesen, E. B. (2007) · Thyroid · doi:10.1089/thy.2007.0165 · Cited by 25
Mazokopakis, E. E., Starakis, I., Papadomanolaki, M. G., Batistakis, A. G., & Papadakis, J. A. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115612 · Cited by 24
Exercise Performance in Young and Middle-Aged Female Patients with Subclinical Hyperthyroidism
Portella, R. B., Silva, J. L. D. C., Wagman, M. B., de Oliveira, F. P., Buescu, A., & Vaisman, M. (2006) · Thyroid · doi:10.1089/thy.2006.16.731 · Cited by 23
Guía clínica del diagnóstico y tratamiento de la disfunción tiroidea subclínica
Hernández, J. J. C., Alonso, N., Blanco, A. C., Ferrater, J. C. G., Pérez, A., Morales, T. L., Corral, B. P., & Henzi, F. T. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71404-3 · Cited by 20
Sökmen, A., Acar, G., Sokmen, G., Akçay, A., Akkoyun, M., Köroğlu, S., Nacar, A. B., & Özkaya, M. (2013) · Echocardiography · doi:10.1111/echo.12277 · Cited by 19
HATCH, M. C., Furukawa, K., Brenner, A. V., Olinjyk, V., Ron, E., Zablotska, L. B., Terekhova, H. М., McConnell, R., Markov, V. V., Shpak, V., et al. (2010) · Radiation Research · doi:10.1667/rr2003.1 · Cited by 19
Janus, I., Noszczyk-Nowak, A., Bubak, J., Tursi, M., Vercelli, C., & Nowak, M. (2023) · Veterinary Quarterly · doi:10.1080/01652176.2023.2234436 · Cited by 17
Position de consensus: apport des examens biologiques dans le diagnostic de surentraînement
Bricout, V., Guinot, M., Duclos, M., Koulmann, N., Serrurier, B., Brun, J. ‐., Flore, P., Chatard, J., Bigard, X. A., & Favre‐Juvin, A. (2006) · Science & Sports · doi:10.1016/j.scispo.2006.09.002 · Cited by 18
Kebamo, T. E., Tantu, A., Solomon, Y., & Walano, G. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01851-1 · Cited by 16
Thyroid-Stimulating Hormone Is Significantly Associated with Bone Health Status in Men
Chin, K., Ima-Nirwana, S., Mohamed, I. N., Aminuddin, A., Johari, M. H., & Ngah, W. Z. W. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5870 · Cited by 16
Subclinical hyperthyroidism impacts left ventricular deformation: 2D and 3D echocardiographic study
Tadic, M. V., Ilic, S., Cuspidi, C., Marjanovic, T., & Celic, V. P. (2015) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2015.1015441 · Cited by 16
Serum trace element and amino acid profile in children with cerebral palsy
Tinkov, A. A., Геннадиевна, С. М., & Skalny, A. V. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126685 · Cited by 15
Nacar, A. B., Acar, G., Yorgun, H., Akçay, A., Özkaya, M., Canpolat, U., Akkoyun, M., & Tuncer, C. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01718.x · Cited by 15
Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
Rizzo, C., Gioia, M. I., Parisi, G., Triggiani, V., & Iacoviello, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_132 · Cited by 14
Endogenous subclinical hyperthyroidism: Metabolic and cardiac parameters
Ψαλτοπούλου, Θ., Ilias, Ι., Toumanidis, S. T., Mantzou, A., Marafelia, P., Gd, P., Koutras, D. A., & Alevizaki, M. K. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.12.010 · Cited by 14
Thyroid cancer: possible role of telemedicine.
Gibelli, G., Gibelli, B., & Nani, F. (2008) · PubMed Central · Cited by 14
Cozzi, R. C., & Attanasio, R. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.2.129 · Cited by 14
Yu, J., Kaur, R., Ayeni, F. E., Eslick, G. D., & Edirimanne, S. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2084-3408 · Cited by 13
Pandey, R., Jaiswal, S., Bastola, J. P. S. K., & Dulal, S. (2018) · Cited by 13
Functional and molecular thyroid imaging
GIOVANELLA, L., & Ovčariček, P. P. (2022) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.22.03428-8 · Cited by 12
Barasch, E., Gottdiener, J. S., Bůžková, P., Cappola, A. R., Shah, S. J., deFilippi, C. R., Gardin, J. M., & Kizer, J. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae001 · Cited by 11
Tadić, M., Cuspidi, C., Vasić, D., & Kerkhof, P. L. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_29 · Cited by 10
Metadata
- Authors
- Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G.
- Affiliations
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
- Institut Gustave Roussy (FR)
- Corresponding author
- Biondi, Bernadette
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01
- Volume
- 152
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2051330706
- Cited by
- 217
- References
- 114
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 4 · 2016: 18 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 15
- FWCI
- 2.11
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical hyperthyroidism, TSH suppression, levothyroxine, thyroid nodules, differentiated thyroid cancer, quality of life, cardiovascular effects, supraventricular arrhythmias, left ventricular hypertrophy, diastolic dysfunction, exercise intolerance, osteoporosis, postmenopausal women, treatment options
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Cardiovascular Diseases, Female, Humans, Hyperthyroidism, Osteoporosis, Thyrotropin, Thyroxine, Triiodothyronine, Bisoprolol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review